| 000 | 01483 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517164624.0 | ||
| 264 | 0 | _c20180713 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs-2017-0054 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGautier-Veyret, Elodie | |
| 245 | 0 | 0 |
_aPharmacogenetics may influence the impact of inflammation on voriconazole trough concentrations. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cAug 2017 |
||
| 300 |
_a1119-1123 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2C19 _xgenetics |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aVoriconazole _xadministration & dosage |
| 700 | 1 | _aBailly, Sebastien | |
| 700 | 1 | _aFonrose, Xavier | |
| 700 | 1 | _aTonini, Julia | |
| 700 | 1 | _aChevalier, Simon | |
| 700 | 1 | _aThiebaut-Bertrand, Anne | |
| 700 | 1 | _aStanke-Labesque, Françoise | |
| 773 | 0 |
_tPharmacogenomics _gvol. 18 _gno. 12 _gp. 1119-1123 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs-2017-0054 _zAvailable from publisher's website |
| 999 |
_c27404343 _d27404343 |
||